The once-daily pill, currently under investigation, is being studied for adults with type 2 diabetes who are not on any ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...

Similarly, the price of anti-diabetic medicines like Dapagliflozin ... drug of Atorvastatin and Clopidogrel, used in the treatment of cardiac ailments, increased from Rs 266.5 per strip to Rs ...

The scientists found that two medications significantly reduce the risk of developing dementia in life. A new study, ...

Health and Human Services Secretary Robert F. Kennedy Jr. has been critical of the drugs, instead placing a focus on ...

Unfortunately, rather than addressing the fundamental lifestyle factors that contribute to Type 2 diabetes, patients and providers have become increasingly reliant on medications that slow the ...

Recent study shows oral semaglutide reduces cardiovascular risk in type 2 diabetes patients, enhancing diabetes and heart ...

finds that people with type 2 diabetes who take two common anti-diabetes medications had a reduced risk of Alzheimer’s and associated dementias. Specifically, GLP-1RA was linked to a 33% lower ...